Jeffrey A Brinker, M.D.

• Professor of Medicine

https://www.hopkinsmedicine.org/profiles/results/directory/profile/0001297/jeffrey-brinker

Glucagonoma and the glucagonoma syndrome-cumulative experience with an elusive endocrine tumour treatment yeast infection home order divalproex 250 mg free shipping. Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years medications given for uti generic divalproex 250 mg on-line. The top of the bullae frequently detaches or ruptures medications on carry on luggage purchase divalproex overnight, leaving eroded areas that crust treatment yeast infection nipples breastfeeding divalproex 250 mg with mastercard. The lesions tend to heal in the center whereas the edges continue to spread treatment hiccups divalproex 500 mg purchase on-line, with a crusting welldefined edge. Fusiform keratinocytes with pyknotic nuclei are often seen, as are mononuclear inflammatory infiltrates. Weight loss, often profound and associated with anorexia, occurs in most patients,11,90,183186 even with small, nonmetastatic tumors. Mild anemia, usually normocytic and normochromic with normal serum iron, folate, and vitamin B12 levels, can respond to successful tumor therapy. Most glucagonoma patients have a markedly elevated plasma glucagon level at presentation,11,12,90,182,183,186,206 with a mean plasma glucagon concentration of 2110 pg/mL (range, 550 to 6600 pg/mL). Treatment Medical Treatment Initial medical treatment is directed at relieving symptoms, restoring nutritional status, and controlling hyperglycemia as tumor localization studies (discussed later) are being performed. The catabolic effects of glucagon combined with glucose intolerance and diabetes mellitus can markedly affect the nutritional status of these patients. Their heightened risk of venous thromboembo lism increases postoperative morbidity. Plasma glu cagon levels decrease in 80% to 90% of treated patients, but into the normal range in only 10% to 20%. Surgical Treatment Surgical resection should be considered in all patients with local ized tumors. The syndrome is characterized by extreme watery diarrhea, hypochlorhydria, achlorhydria, and hypokale mia (see Tables 34. The patients may require 5 or more L/day of fluid11 and over 350 mEq/day of potassium. Surgical Treatment Once the fluid and electrolyte deficits are corrected, patients should undergo imaging studies (discussed later) to assess tumor resectability. After performing these imaging studies, surgical cure should be considered for all patients without metastatic dis ease. In addition to antitumor treatment, bisphosphonates can be used to control the hypercalcemia. Due to the relatively subtle clinical manifestations of the somatostatinoma syndrome, this diagnosis is exceedingly rare. The median time from initial symptoms to diag nosis varies from 6 months to almost 3 years. Presenting symptoms/signs from the tumor include abdominal pain, jaundice, and weight loss. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. For correct classification of gastric carcinoids into these types, the mucosa of the gastric antrum and the body/fundus should both be sampled, in addition to the removal or biopsy of the lesions. Metastases are also more common in type 2 than type 1,116,250,257,260 and the 5year survival in patients with type 2 gastric carcinoids is lower than in type 1 (see Table 34. Neuroendocrine tumors of the stomach [gastric carcinoids] are on the rise: small tumors, small problems The 5year survival rate is close to 50%, and 25% to 30% of type 3 patients have a tumorrelated death. In one study253 of patients with type 1 gastric carcinoids treated endoscopically, survival was 100% during the 46month followup; no metas tases occurred, a single patient developed a less differentiated tumor requiring surgery, and 64% had a recurrence after a median of 8 months, treated endoscopically. If distant metastases are not present, these patients should be managed surgically. For example, about 46% of tumors smaller than 1 cm are associated with liver metastases. Typical carcinoid flush involving the face and neck in a patient with small intestinal carcinoid and the carcinoid syndrome. Their tumors are similar clinically to spo radic cases and share frequent aberrations in chromosome 18. They are predominantly welldifferentiated (G1) tumors, with 9% to 19% of them G2 and 2% G3. Recurrent cases of bowel obstruction may also occur, either due to primary intestinal tumor or mesen teric metastases. Weight loss and hepatomegaly are other signs/ symptoms associated with these tumors. Symptoms of carcinoid heart disease (dyspnea, edema) are often late manifestations of disease. A separate type of appendiceal malignancy, adenocarcinoid (also known as goblet cell carcinoid) is entirely distinct in clinical behavior and treatment. Other negative prognostic factors include location of the tumor at the base of the appendix, greater than 3 mm invasion into the mesoappendix, highgrade tumors, and positive resection margins. Standard polypectomy can usually be performed, but if local mucosal/submucosal invasion is present, a more extensive endo scopic procedure may be appropriate. Pathophysiology the carcinoid syndrome occurs when sufficient concentrations of hormonal products released by the tumor reach the systemic circulation. Its occurrence and severity are related to the tumor size in areas that drain into the systemic circulation. In more than 90% of cases, this syndrome occurs with metastatic disease, espe cially to the liver. Surg Gynecol Obstet 1973;137:637­44; Norheim I, Oberg K, Theodorsson-Norheim E, et al. An analysis of 103 patients with regard to tumor localization, hormone production, and survival. J Exp Clin Cancer Res 1999;18:134­41; Norheim I, Oberg K, TheodorssonNorheim E, et al. Aliment Pharmacol Ther 2003;17:437­44; Ruszniewski P, Ish-Shalom S, Wymenga M, et al. Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotide. Long-term results of treatment of malignant carcinoid syndrome with prolonged release Lanreotide (Somatuline Autogel). Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon. The pathogenesis of diarrhea in patients with carcinoid syn drome is also complex. Serotonin may also be involved in other fibrotic reactions sometimes seen in the carcinoid syn drome, such as retroperitoneal fibrosis. Note fibrotic thickening of the cusps of the pulmonary valve and the endocardium in a patient with small intestinal carcinoid tumor and liver metastases. Flushes may be spontaneous or be precipitated by stress, alcohol, certain foods such as cheese, or exercise, or be pharmacologically induced by injections of catecholamines, calcium, or pentagas trin. The flushing with respiratory tract carcinoids has a greater tendency to cause diffuse body involvement, and after repeated flushing of this type, patients may develop a constant red or cyanotic col oration. It is frequently provoked by food intake, with erythema associ ated with blotches and wheals with central clearing, frequently occurring around the neck and on the arms, and the lesions are frequently associated with pruritus. Both octreotide and lanreotide share a similar mechanism of action, binding avidly to somatostatin recep tor subtype 2, and to a lesser extent with subtype 5. Longterm side effects are usually mild and uncom monly lead to drug discontinutation. After a 12week double blind duration, mean reductions in daily bowel movements were 0. As a result of this trial, the 250 mg tid dose of telotristat was approved for management of refractory diarrhea. In patients with symptomatic carcinoid heart disease, valve replacement surgery is typically indicated. Studies have shown that an appropriately ordered68Gadotatate scan can influence clini cal decision making in a substantial proportion of cases. Although they are widely used and mentioned in manage ment guidelines, there are no completed randomized trials compar ing them. With the recogni tion of these poor prognostic factors, the overall 5year sur vival rate increased to 59% after the year 2000. Reanalysis for additional predictors of poor outcome identified age older than 45, hepatomegaly, and major or minor resective surgery concurrent with liver transplantation. Median time to progression, the primary endpoint, improved from 6 months on placebo to 14. Side effects of lanreotide included diarrhea, abdominal pain, and cho lelithiasis. However, longterm radiationinduced liver disease represents an important concern, particularly in patients with extensive bilobar metastases. The most common grade 3 or 4 side effects were myelosuppres sion, diarrhea, stomatitis, or hyperglycemia, ranging in incidence from 3% to 7%; these side effects were generally manageable by dose reduction or drug interruption. Risks versus benefits need to be carefully weighed, partic ularly in patients who are older, frail, or have clinically significant comorbidities such as lung disease or diabetes. In one study of 87 patients, objective radiographic responses observed with 90Ydotataoc were 28%. Another study, evaluating only patients with refractory carcinoid syndrome, demonstrated an objective response rate of only 4%, but a high rate of stable dis ease (70%). Longterm myelo toxicity (myelodysplastic syndrome or acute leukemia) occurs in roughly 2% of patients. With use of prophylactic amino acid infusions, rates of grade 3 or 4 nephrotoxicity have been <1%. The objec tive response rate with 177Ludotatate was 18% compared to 3% with highdose octreotide. There is evidence that degree of somatostatin receptor expression correlates with tumor response. There is no clear correlation between total treatment dose and risk of irreversible myelotoxicity. The regimen was welltolerated with a 13% rate of grade ¾ neutropenia and a 8% rate of grade ¾ thrombocyto penia. These agents induce remission in 14% to 80% of patients, with a mean duration of response of less than 12 mon ths. Chemoradiation is another option for patients with local or locoregional poorly differentiated neuroen docrine carcinoma and is the treatment of choice for locoregional small cell carcinoma of the esophagus. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus pro cess to the development of a minimum pathology data set. Primary peptic ulcerations of the je junum associated with islet cell tumors of the pancreas. Characterization of a growth hormonereleasing factor from a human pancreatic islet tumour. Successful treatment of acromegaly by removal of a pancre atic islet tumor secreting a growth hormonereleasing factor. Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances. Calcitoninsecreting pan creatic endocrine tumors: systematic analysis of a rare tumor entity. Elevated serum ghrelin exerts an orexigenic effect that may maintain body mass index in patients with metastatic neuroendocrine tumors. Trends in the incidence, prevalence, and survival outcomes in patients with neuroen docrine tumors in the United States. One hundred years after "car cinoid": epidemiology of and prognostic factors for neuroendo crine tumors in 35,825 cases in the United States. Recent advances in pathophysiology and manage ment of inflammatory bowel diseases and digestive endocrine tumors. Prognostic validity of a novel American Joint Committee on cancer staging classification for pancreatic neuroendocrine tumors. Somatostatinoma: clinico pathological features of three cases and literature reviewed. Somatostatinproducing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity. Prospective study of clinical significance and of the development of a second symp tomatic pancreatic endocrine tumor syndrome. The pathologic classifi cation of neuroendocrine tumors: a review of nomenclature, grad ing, and staging systems. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. Somatostatinoma/inhibitory syndrome: a statisti cal evaluation of 173 reported cases as compared to other pancreatic endocrinomas. Insulin, Cpeptide and pro insulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism. Nationwide cohort study of postgastric bypass hypoglycaemia including 5,040 patients under going surgery for obesity in 19862006 in Sweden. Patients with neuroglyco penia after gastric bypass surgery have exaggerated incretin and in sulin secretory responses to a mixed meal. Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery. Insulinomatosis: a multicen tric insulinoma disease that frequently causes early recurrent hyper insulinemic hypoglycemia.

Whereas Italians were satisfied to hear that the pain was not a serious problem medicine cabinet home depot divalproex 500 mg with visa, the Jewish patients needed to understand the meaning of the pain and its future consequences ok05 0005 medications and flying generic divalproex 500 mg buy on line, perhaps because of the importance of knowledge acquisition within the culture k-9 medications order divalproex 250 mg mastercard. For example 97110 treatment code cheap divalproex 250 mg amex, there is no word in Spanish to define the concept of "bloating treatment 1st metatarsal fracture buy 250 mg divalproex overnight delivery," a symptom commonly reported in English-speaking countries. They may therefore influence the intestinal microbiota, host immune function, and treatment recommendations. Cultural influences affect the interpretation of symptoms as an illness requiring health care, to be self-treated, or to be ignored. Diarrhea is often not considered an illness requiring health care among Mexicans, because it is so common and pervasive. When given the option, the Romani (gypsies) will select only the top physicians (ganzos) to take care of a family member and will not follow the recommendations of others. If a clinician prescribes a "hot" medicine (not related to temperature) for a "hot" illness, the patient might not take that medicine because it would disrupt the balance of humors in the body. In addition, coping style and social support provide modulating (buffering) effects. Examples of pathologic traits include borderline, obsessive-compulsive, or paranoid personality disorders; they are not amenable to specific pharmacologic or psychotherapeutic treatments. During the psychoanalytically dominated era of psychosomatic medicine (1920 to 1955), certain psychological conflicts were believed to underlie the development of personalities that expressed specific psychosomatic diseases. Investigators now view personality and other psychological traits as enablers or modulators of illness. Psychiatric Diagnosis Psychiatric diagnoses are definable collections of psychological symptoms and behaviors (Axis I). This co-occurrence of a psychiatric diagnosis in patients with a medical disorder (comorbidity) is more commonly seen in referral than primary practices, and the psychiatric diagnosis aggravates the clinical presentation and outcome of the medical disorder. In this diagnostic category, somatic symptoms may or may not be medically unexplained but are distressing, disabling, and associated with excessive and disproportionate thoughts, feelings, and behaviors for more than 6 months. It is a bidirectional system in which thoughts, feelings, and memories lead to neurotransmitter release (the software) that affects sensory, motor, endocrine, autonomic, immune, and inflammatory function. In effect, the brain-gut axis is the neuroanatomic and neurophysiologic substrate for the clinical application of the biopsychosocial model. Johnny from Case 2, who reported somatic symptoms when distressed, may not have recognized or communicated the association of symptoms with the stressful antecedents because these antecedents were not acknowledged or attended to within the family. The stimulus can be a biological event such as infection, a social event such as a change of residence, or even a disturbing thought. Some stimuli, such as pain, sex, or threat of injury, often elicit a predictable response in animals and humans. A divorce might be considered a positive experience for one person and a disappointment for another. A stimulus can produce a variety of responses in different persons or in the same person at different times. The effect may not be observed or may be a psychological response (anxiety, depression), a physiologic change (diarrhea, diaphoresis), the onset of disease (asthma, colitis), or any combination of these. Coping has been defined as "efforts, both actionoriented and intrapsychic, to manage. Gastric hyperemia and increased motility and secretion were linked to feelings of anger, intense pleasure, or aggressive behavior toward others. Conversely, mucosal pallor and decreased secretion and motor activity accompanied fear or depression, states of withdrawal. This observation is not surprising because the hardwiring between brain and gut is established from an anlage that begins as one unit (neural tube) and then differentiates with the growing organism into the "big brain" and the "little brain" in the gut. This figure shows the development of the nervous system in the embryo beginning with the neural crest. Over time, the neural crest grows and differentiates into the forebrain, midbrain, and spinal cord. This helps explain the clinical observation of the close relationship between psychosocial features and gut functioning, the brain-gut axis. This helps explain the close relationship clinically between psychosocial features and gut functioning: the brain-gut axis. Peptides may be secreted at nerve endings as neurotransmitters or directly from cell walls and thus have local or paracrine effects. Biological amines such as serotonin, norepinephrine, and dopamine act in the periphery to mediate the effects of the sympathetic nervous system to regulate the balance between constipation and diarrhea and centrally to modulate mood, emotional behavior, and pain. The opioid system can raise the threshold for pain and impair peristalsis and secretion; centrally it may paradoxically produce hyperalgesia. Therefore, because certain areas of the brain have the capability to up- or downregulate incoming visceral signals, neurotransmitters common to both brain and gut. Growing evidence suggests that disease activation is influenced by psychosocial vulnerabilities, including perceived stress, maladaptive coping, and psychiatric comorbidities. It is important to note that visceral pain perception does not necessarily map directly to the degree or intensity of peripheral afferent input but rather is amplified through cognitive and affective circuits at the level of the brain and through descending modulatory pathways. For example, negative affectivity, including neuroticism and somatization, affect the processing and modulation of visceral pain in a variety of health conditions. Furthermore, as pain becomes more severe, central mechanisms begin to play a larger role in symptom experience. Sensitization of primary afferent pathways can occur in response to infection, trauma, and other factors that cause inflammation, as well as dysmotility from repeated distension. Stress-mediated mast cell degranulation, particularly near enteric neurons, is associated with sensitization of afferent neurons. These systems are influenced by numerous positive and negative feedback systems that allow behavioral and peripheral adaptations to stress. Finally, the glucocorticoids suppress inflammation and cytokine production, thereby completing the negative feedback loop. After the first-order visceral neurons are stimulated, they project to the spinal cord, where they synapse with second-order neurons and ascend to the thalamus and midbrain. For most patients with mild-to-moderate symptoms, environmental and bowel-related factors. Patients with moderate-to-severe symptoms also have impaired central modulation of pain as a result of various psychosocial factors, with decreased central inhibitory effects on afferent signals at the level of the spinal cord (disinhibition). In effect, the more severe and constant the pain and the more it is associated with other comorbid symptoms, the more likely the pain is predominantly centrally mediated. Repeated stimulation of the first-order neurons leads to sensitization of spinal circuits, thereby increasing the signal originating from the dorsal horn synapse and then via second-order neurons to the brain. Central sensitization may also be enhanced at the level of the brain through connections from centers that subsume stressrelated activation. When peripheral influences on severity predominate, medications, surgery, or other modalities that act on the intestine are the primary treatment considerations. As pain becomes more severe, however, behavioral and psychopharmacologic treatments must be added. This figure shows the ascending visceral pathways from the intestine to somatosensory and limbic structures in the brain via spinal and midbrain pathways. This pathway is important for sensory discrimination and localization of visceral and somatic stimuli. The spinoreticular tract (middle pathway) conducts sensory information from the spinal cord to the brainstem (reticular formation). This region is involved mainly in the affective and motivational properties of visceral stimulation, that is, the emotional component of pain. The reticulothalamic tract projects from the reticular formation to the medial thalamus on the left, and then to the cingulate cortex. This multicomponent integration of nociceptive information, dispersed to the somatotypic-intensity area (lateral sensory cortex) and to the emotional or motivational-affective area of the medial cortex, explains variability in the experience and reporting of pain. Stress-Mediated Effects Brain imaging studies have shown preferential activation of various sites in the limbic system of the brain as a result of psychological distress, rectal distension, and other stimuli compared with control subjects. This figure conceptualizes brain-gut influences on symptom severity (horizontal axis). For the smaller group of patients with moderate to severe symptoms, central modulation of pain is impaired, leading to decreased central inhibitory effects on afferent signals at the level of the spinal cord (disinhibition). Factors that contribute to this effect may include life stress and abuse, comorbid psychiatric diagnoses, and poor coping. Knowing the purported site of action (intestine, brain, or both) can help in determining the treatment approach, such as whether to use medications that target the intestine or brain. Repeated stimulation of the first-order neuron leads to sensitization of spinal circuits, thereby increasing the signal originating from the dorsal horn synapse and then via second-order neurons to the brain. Central sensitization may also be enhanced at the level of the brain through connections from centers subsuming stress-related activation. The psychological effects of abuse or wartime exposure may produce disruption in central pain modulation systems and in brain circuits at the interface of emotion and pain. The result is an increase in physical and psychological symptoms and more intense pain and syndromes. The descending pathway is consistent with the gate control theory of pain modulation. Psychological treatments and antidepressants are thought to activate these descending pathways. Their continued symptoms, restricted activity, and health care tax family, friends, and physician, all of whom may feel helpless to provide enough emotional or medical assistance. The family must then deal with feelings of guilt and anger, the expressions of which, although unavoidable, are not usually socially permitted. Often the physician carries the burden of the feelings of the patient and family and must reconcile the 2. In most cases, the problems are worked out, and the patient establishes a pattern of coping. If the patient has limited capacity to cope psychologically Cytokines and the Brain Stress may have proinflammatory effects, but intestinal inflammation may also affect behavior reciprocally via activation of cytokines. Inflammation can affect neurotransmitter metabolism, neuroendocrine function, and neural plasticity in the brain, and there is increasing evidence that major depression and other psychiatric disorders may be mediated by inflammatory factors. The recommendations offered here are particularly useful for patients who have chronic illness or major psychosocial difficulties. The clinical features are clearer, and additional information about an association of symptoms with beginning a new job situation is obtained. This interview method also encourages patient self-awareness and allows consideration of possible behavioral treatments. Consider the information obtained in the following office interview: Physician (looking at chart): "How can I help you Furthermore, the nonverbal communication did not facilitate an effective physician-patient interaction. The medical history should be obtained through a patient-centered, nondirective interview during which the patient is encouraged to tell the story in his or her own way so that the events contributing to the illness unfold naturally. Open-ended questions are used initially to generate hypotheses, and additional information is obtained with facilitating expressions-"Yes Avoid closed-ended (yes-no) questions at first, although they can be used later to characterize the symptoms further. The traditional medical and social histories should not be separated but elicited together, so that the medical problem is described in the context of the psychosocial events surrounding the illness. Determining whether psychosocial or biological processes are operative in an illness is unnecessary and possibly countertherapeutic. Usually, both are important, and treatment is based on determining which is identifiable and remediable. A negative medical evaluation is not sufficient for making a psychosocial diagnosis. Diagnostic Decision Making Deciding which tests to order will depend on their clinical usefulness. This temptation can be avoided by basing decisions on the objective evaluation of data. L (Case 1), the patient with persistent and unexplained abdominal pain, is an example familiar to the gastroenterologist. The urge to work up a patient with chronic abdominal pain must be tempered by the evidence that an adequate initial evaluation considerably reduces the likelihood of finding an overlooked cause later. Here, the clinical approach is not medical diagnosis but psychosocial assessment and treatment of the chronic pain. Experienced physicians usually make diagnostic and treatment decisions based on the degree of change in the condition over weeks or months, rather than on 1 or 2 occasions. Consultation with a psychiatrist or health psychologist should be considered when additional psychological data could clarify the illness or improve patient care. The physician should limit discussion about symptoms to what is needed to satisfy medical concerns and focus instead on adaptations to the illness rather than the cure. When the patient is unwilling or unable to accept the role of psychosocial factors in illness, the physician can still obtain such information indirectly by inference and should not attempt to provide the patient with insight. Consistent with the biopsychosocial model of illness, discussing psychosocial and biological factors in terms of causation. If the reassurance is premature, inadequate, or inappropriate, it will be perceived as insincere or as a lack of thoroughness by the physician. For example, disability may be a disincentive to helping the patient re-establish wellness and return to gainful employment. If the patient does not qualify for disability, the physician should be clear about it. For some patients, more may be lost by giving up the state of illness than gained by wellness, and improvement may be slow. The patient can be helped by improving his or her psychosocial adjustment to the illness. Their noradrenergic and anticholinergic effects also reduce intestinal transit rate and can therefore help patients with diarrhea.

Buy generic divalproex 250 mg. The Symptoms of General Anxiety and Panic Disorder.

Endoscopic sphincterotomy for acute relapsing pancreatitis associated with periampullary diverticula: a long-term follow-up medicine 3 sixes cheap divalproex 250 mg free shipping. Influence of juxtapapillary diverticulum on hepatic clearance in patients after endoscopic sphincterotomy 714x treatment purchase divalproex 500 mg otc. Function of the sphincter of Oddi in patients with juxtapapillary duodenal diverticula: evaluation by intraoperative biliary manometry under a duodenal pressure load medicine jokes discount divalproex 500 mg fast delivery. Predictors for bile duct stone recurrence after endoscopic extraction for naïve major duodenal papilla: a cohort study shinee symptoms divalproex 500 mg overnight delivery. Influence of juxtapapillary diverticula on the success or difficulty of cannulation and complication rate treatment gout divalproex 500 mg buy on line. Intraluminal duodenal diverticula: collective review with report of a laparoscopic excision. Acute bleeding and anemia associated with intraluminal duodenal diverticulum: case report and review. The clinical significance of jejunal diverticular disease diagnosed by double-balloon enteroscopy for obscure gastrointestinal bleeding. Complicated jejunal diverticulitis: a challenging diagnosis and difficult therapy. Enterolith ileus: liberated large jejunal diverticulum enterolith causing small bowel obstruction in the setting of jejunal diverticulitis. Jejunal diverticulum enterolith causing perforation and upper abdominal peritonitis. Intraluminal duodenal diverticulum causing recurrent pancreatitis: treatment by endoscopic incision. Endoscopic removal of entrapped coins from an intraluminal duodenal diverticulum 20 years after ingestion. Congenital duodenal diverticula: a report of three cases and a review of the literature. Endoscopic treatment of intraluminal duodenal ("windsock") diverticulum: varying techniques from five cases. A heterogenous disorder caused by a variety of abnormalities of smooth muscle or myenteric plexus. Capsule endoscopy versus push enteroscopy in patients with occult gastrointestinal bleeding. Analysis of clinical manifestations of symptomatic acquired jejunoileal diverticular disease. Technically, all these hernias are hiatal hernias because they pass through the esophageal hiatus of the diaphragm. Etiology and Pathophysiology Sliding hiatal hernias (type I) occur when the gastroesophageal junction and some portion of the stomach are displaced above the diaphragm, but the orientation of the stomach axis is unchanged. The phrenoesophageal membrane anchors the gastroesophageal junction to the diaphragm (see Chapters 43 and 46). Hiatal hernias may be caused by age-related deterioration of this membrane, combined with normal positive intra-abdominal pressure and traction of the esophagus on the stomach as the esophagus shortens during swallowing. The gastroesophageal junction remains in a normal position at the level of the diaphragm, because there is preservation of the posterior phrenoesophageal ligament and normal anchoring of the gastroesophageal junction, and only the stomach moves proximally. When diagnosing a hiatal or paraesophageal hernia, important questions for the radiologist to address include: (1) Does the gastroesophageal junction lie at or above the hiatus Abdominal wall hernias protrude through the muscular and fascial walls of the abdomen and have 2 parts: (1) the orifice or defect in the aponeurotic wall of the abdomen, and (2) the hernia sac, which consists of peritoneum and abdominal, contents. Abdominal wall hernias are external if the sac protrudes through the abdominal wall or interparietal if the sac is contained within the abdominal wall. Internal hernias are contained within the abdominal cavity and do not always have a hernia sac. Hernias are reducible when the protruding contents can be returned to the abdomen and irreducible or incarcerated when they cannot. A hernia is strangulated when the vascular supply of the protruding organ is compromised, and as a consequence the organ becomes ischemic or necrotic. An incarcerated hernia is generally repaired because there is danger of strangulation, which can result in the loss of bowel. Because it can be difficult to determine whether a hernia is incarcerated or strangulated, incarcerated hernias are considered urgent and treated with surgical intervention. Another type of hernia is a Richter hernia, where only one side of the bowel (most often the antimesenteric side) protrudes through the hernia orifice. As opposed to other hernias, strangulation may occur in a Richter hernia without intestinal obstruction, making this type of hernia a diagnostic challenge. Epidemiology Estimates of the prevalence of hiatal hernia vary widely, ranging from 14% to 84% of patients examined, depending on the patient population, method of diagnosis, and symptoms present. Patients with symptomatic paraesophageal hernias are most often middle-aged to older adults. Hiatal and Paraesophageal Hernias the most common diaphragmatic hernias are sliding hernias of the stomach through the esophageal hiatus, which include Clinical Features, Diagnosis, and Complications Many patients with small simple sliding hiatal hernias are asymptomatic. Barium study showing a paraesophageal hernia with a portion of the stomach above the diaphragm. The gastroesophageal junction remains in a relatively normal position below the diaphragm (arrow). C, the retroflexed endoscopic view of the proximal stomach demonstrates the endoscope traversing a sliding hiatal hernia adjacent to a large paraesophageal hernia. In addition to heartburn and regurgitation, patients with large sliding hiatal hernias may complain of dysphagia or discomfort in the chest or upper abdomen. With chest radiography, a hiatal hernia may be noted as a soft tissue density or an air-fluid level in the retrocardiac area. At endoscopy, the gastroesophageal junction is noted to be proximal to the impression of the diaphragm. Patients with paraesophageal or mixed hiatal hernias are rarely completely asymptomatic if closely questioned. Many patients with paraesophageal hernias have gastroesophageal reflux, particularly those with larger paraesophageal hernias. Cameron lesions or linear erosions may develop in patients with sliding hiatal hernias, particularly large hernias (see Chapter 20). This is the location of the rigid anterior margin of the hiatus formed by the central tendon of the diaphragm. Mechanical trauma, ischemia, irritation by pills, and peptic injury have been proposed as the cause of these lesions. The prevalence of Cameron lesions in patients with hiatal hernias who undergo endoscopy has been reported to be about 5%, with the highest prevalence in the largest hernias, with rates of approximately 30% in paraesophageal hernias referred for surgical repair. Symptoms include acute abdominal pain and retching, and it can progress rapidly to a surgical emergency (see "Gastric Volvulus"). Endoscopy may be difficult if the hernia is associated with gastric volvulus, and reaching the pylorus may be a challenge due to positioning of the stomach. Patients with symptomatic giant sliding hiatal hernias, paraesophageal, or mixed hernias should be offered surgery. One should pay careful attention to chest pain and postprandial shortness of breath; these may be symptoms related to the paraesophageal hernia. Indeed, patients with pulmonary issues may benefit from having their paraesophageal hernias repaired to create room in the chest and decrease aspiration events. The extent of the preoperative evaluation needed for paraesophageal hernia repair is controversial. Patients often have already had a barium esophagogram or other esophageal study that characterizes the paraesophageal hernia. Many surgeons recommend routine preoperative evaluation with esophageal manometry and ambulatory esophageal pH monitoring because of the high prevalence of associated gastroesophageal reflux and esophageal motility disorders, while others may forgo pH testing and use reflux symptoms as a guide for the type of repair chosen. Options for assessment of esophageal pH include 24-hour impedance/ pH testing and 48-hour wireless capsule pH monitoring. The object of manometric evaluation is to determine whether the patient has a significant motility disorder. However, esophageal manometry is challenging in these patients, and anatomic distortions can make it difficult to identify the lower esophageal sphincter, making this measurement unreliable. Many surgeons routinely add a fundoplication to hernia repairs to prevent postoperative reflux esophagitis and to fix the stomach in the abdomen. However, in patients with motility disorders, the surgeon may elect to perform a loose anterior wrap (Dor fundoplication) or use a gastrostomy tube or gastropexy to fix the stomach intra-abdominally. These elements can be accomplished minimally invasively (laparoscopically or robotically), or via open operation performed through the abdomen or chest. Injury to the lung can occur with vigorous traction; however, as the diaphragmatic defect is central (medial) rather than peripheral (lateral), as in a traumatic defect, intense lung adhesions are usually not present. Resection of the hernia sac can result in violation of the left chest, requiring chest tube placement. Reconstruction of the diaphragm can be performed by placing nonabsorbable sutures posterior to the esophagus. However, most surgeons are wary of using synthetic mesh close to the esophagus, and therefore "biological" products are favored. Keyhole mesh can be used, in which the esophagus is completely encircled with mesh, with the concern being dysphagia in this situation. Fixation of the stomach in the abdomen is usually achieved by using a fundoplication, which provides some bolstering effect at the hiatus to keep the stomach in the abdomen and can reduce postoperative gastroesophageal reflux. Additional use of gastropexy, with suturing of the stomach to the abdominal wall or gastrostomy tube placement for 2 weeks to allow the stomach to mature to the abdominal wall, may result in fewer recurrences. Patients with sliding hiatal or paraesophageal hernias may have shortening of the esophagus. This makes it difficult to restore the gastroesophageal junction below the diaphragm without tension, a key factor in decreasing recurrence. In such cases, an extra length of neoesophagus can be constructed from the proximal stomach (Collis-Nissen procedure). Alternatively, transmediastinal dissection of the esophagus for more than 5 cm into the chest will usually result in adequate intra-abdominal length of esophagus without the need for additional stapling. Potential surgical complications include esophageal and gastric perforation, pneumothorax, and liver laceration. Potential long-term complications may include dysphagia if the wrap is too tight or gastroesophageal reflux if the fundoplication breaks down or migrates into the chest. When examined closely, radiographic recurrence after paraesophageal hernia repair is 15% to 25%. The retroflex view from the stomach will demonstrate the presence or absence of a paraesophageal hernia. Morgagni hernias form anteriorly at the sternocostal junctions of the diaphragm, and Bochdalek hernias form posterolaterally at the lumbocostal junctions of the diaphragm. Epidemiology Congenital diaphragmatic hernias occur in about 1/2000 to 1/10,000 births, with some types seen more frequently in males. The presence of intra-abdominal contents in the chest during fetal development results in significant hypoplasia of the lung. Newborns with Bochdalek hernia have respiratory distress, absent breath sounds on one side of the chest, and a scaphoid abdomen. The major causes of mortality in infants with Bochdalek hernias are respiratory failure and associated anomalies, which can include cardiac abnormalities and musculoskeletal defects. The pregnancy is considered high risk when congenital diaphragmatic hernia is diagnosed in the prenatal period. In older children and adults, a Bochdalek hernia may manifest as an asymptomatic chest mass. The differential diagnosis includes mediastinal or pulmonary cyst or tumor, pleural effusion, or empyema. Symptoms, when present, can include pain, pulmonary symptoms, and obstructive symptoms and are due to herniation of the stomach, omentum, colon, or small bowel. The diagnosis may be suspected on a chest radiograph, particularly a lateral view. The key finding is a posterior chest mass, as the defect of Bochdalek is posterior. Diagram of the diaphragm viewed from below with areas of potential herniation shown. A, this plain chest film shows a Bochdalek hernia as a small opacity in the posterior chest at the level of the diaphragm, with bowel in the left chest (arrows). C, Barium enema shows that a portion of the transverse colon is the hernia (top left). Many patients have no symptoms or nonspecific symptoms such as chest discomfort, cough, dyspnea, and upper abdominal distress. Gastric, omental, or intestinal incarceration with obstruction and ischemia may cause acute symptoms. Respiratory or abdominal symptoms manifesting several days to weeks after injury should suggest the possibility of a missed diaphragmatic injury. The diaphragm must be closely inspected to detect injury at the time of exploratory laparotomy or laparoscopy, as these injuries can easily be missed. In patients on ventilatory support after trauma, positive intrathoracic pressure may prevent herniation through a diaphragmatic tear. However, on attempted ventilator weaning, herniation may occur, causing respiratory compromise. The treating physician should consider a traumatic cause when a diaphragmatic defect is not hiatal and is not located in the usual locations of congenital defects. Treatment and Prognosis For infants with Bochdalek hernias, intubation and mechanical ventilation are often needed at the time of delivery. Despite advances in critical care and surgical techniques, the mortality rate is still around 60%, although higher survival rates have been reported by some centers. One must be careful to note the inferior epigastric vessels that are present in the location of the Morgagni hernia.

Interpretation and use of weight information in the evaluation of eating disorders: Counselor response to weight information in a national eating disorders educational and screening program medicine lyrics order generic divalproex on-line. The interaction between eating disorders and celiac disease: an exploration of 10 cases symptoms kidney purchase divalproex online from canada. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids medicine 657 purchase line divalproex. Haematological changes and infectious complications in anorexia nervosa: a case control study medications dictionary generic divalproex 500 mg free shipping. Laboratory screening for electrolyte abnormalities and anemia in bulimia nervosa: a controlled study medicine for vertigo divalproex 250 mg buy mastercard. Abnormalities in plasma and cerebrospinal-fluid arginine vasopressin in patients with anorexia nervosa. Delayed detection of pregnancy in patients with anorexia nervosa: two case reports. Gastric electrical activity assessed by electrogastrography and gastric emptying scintigraphy in adolescents with eating disorders. Increased emergency department use by adolescents and young adults with eating disorders. Delayed gastric emptying in anorexia nervosa is improved by completion of a renutrition program. Psychological features are important predictors of functional gastrointestinal disorders in patients with eating disorders. The association of gastrointestinal symptoms with weight, diet, and exercise in weight-loss program participants. Exploring eating disorder quality of life and functional gastrointestinal disorders among eating disorder patients. Oesophageal and gastric motility disorders in patients categorized as having primary anorexia nervosa. Esophageal motility and symptoms in restricting and binge-eating/purging anorexia. Gastrointestinal consequences of the eating disorders: anorexia nervosa and bulimia. Gastrointestinal complications associated with anorexia nervosa: a systematic review. Anorexia nervosa with severe liver dysfunction and subsequent critical complications. An underlying behavioral disorder in hyperlipidemic pancreatitis: a prospective multidisciplinary approach. Cholinesterase and other serum liver enzymes in underweight outpatients with eating disorders. Primary anorexia nervosa: gastric emptying and antral motor activity in 53 patients. Binge eating disorder treatment: a systematic review of randomized controlled trials. Efficacy of family-based treatment for adolescents with eating disorders: a systematic review and meta-analysis. A randomised controlled treatment trial of two forms of family therapy in adolescent anorexia nervosa: a five-year follow-up. Psychological therapies for adults with anorexia nervosa: randomized controlled trial of outpatient treatments. Cognitive behavior therapy in the posthospitalization treatment of anorexia nervosa. A multicenter comparison of cognitive-behavioral therapy and interpersonal psychotherapy for bulimia nervosa. Comparison of group and individual cognitive-behavioral therapy for patients with bulimia nervosa. Group cognitive-behavioral therapy and group interpersonal psychotherapy for the nonpurging bulimic individual: a controlled comparison. A critical evaluation of the efficacy of self-help interventions for the treatment of bulimia nervosa and binge-eating disorder. Effectiveness of spouse involvement in cognitive behavioral therapy for binge eating disorder. A randomized comparison of group cognitive-behavioral therapy and group interpersonal psychotherapy for the treatment of overweight individuals with bingeeating disorder. The empirical status of the third-wave behavior therapies for the treatment of eating disorders: a systematic review. Dieting and the development of eating disorders in obese women: results of a randomized controlled trial. A randomized comparison of cognitive behavioral therapy and behavioral weight loss treatment for overweight individuals with binge eating disorder. Gastric emptying in patients with restricting and binge/purging subtypes of anorexia nervosa. Rectal prolapse: a possibly under-recognized complication of anorexia nervosa amenable to surgical correction. Incidence of laxative abuse in community and bulimic populations: a descriptive review. Digestive complication in severe malnourished anorexia nervosa patient: a case report of necrotizing colitis. Death due to neurogenic shock following gastric rupture in an anorexia nervosa patient. Death due to duodenal obstruction in a patient with an eating disorder: a case report. Foam bezoar: Resection of perforated terminal ileum in a 17-year-old with sickle beta+ thalassemia and pica. Overview of the treatment of rumination disorder for adults in a residential setting. Transdiagnostic cognitivebehavioral therapy for patients with eating disorders: a two-site trial with 60-week follow-up. Eating disorders-core interventions in the treatment and management of anorexia nervosa, bulimia nervosa and related eating disorders. Short-term cognitive behavioral treatment does not improve outcome on a comprehensive very-low calorie diet program among obese women with binge eating disorder. Effect of a very low calorie diet on the diagnostic category of individuals with binge eating disorder. Efficacy and predictors of longterm treatment success for cognitive-behavioral treatment and behavioral weight-loss-treatment in overweight individuals with binge eating disorder. Exercise augments the effects of cognitive-behavioral therapy in the treatment of binge eating. Binge eating disorder and obesity in 2003: could treating an eating disorder have a positive effect on the obesity epidemic The effect of atypical antipsychotic medications in individuals with anorexia nervosa: a systematic review and meta-analysis. Double-blind placebocontrolled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa. Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial. Effect on bone health of estrogen preparations in premenopausal women with anorexia nervosa: a systematic review and meta-analyses. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures. Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebocontrolled trial. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised double-blind trial. The use of opiate antagonists in treating bulimia: a study of low-dose versus high-dose naltrexone. Outcome and clinical course in inpatient bulimic women: a 2- to 9-year follow-up study. Fluvoxamine in prevention of relapse in bulimia nervosa: effects on eating-specific psychopathology. Fluvoxamine and graded psychotherapy in the treatment of bulimia nervosa: a randomized, double-blind, placebo-controlled, multicenter study of short-term and long-term pharmacotherapy combined with a stepped care approach to psychotherapy [letter]. Orlistat with behavioral weight loss for obesity with versus without binge eating disorder: randomized placebocontrolled trial at a community mental health center serving educationally and economically disadvantaged Latino/as. Novel pharmacologic treatment in acute binge eating disorder-role of lisdexamfetamine. A Phase 3, multicenter, open-label, 12-month extension safety and tolerability trial of lisdexamfetamine dimesylate in adults with binge eating disorder. Refeeding hypophosphatemia in hospitalized adolescents with anorexia nervosa: a position statement of the Society for Adolescent Health and Medicine. Higher caloric intake in hospitalized adolescents with anorexia nervosa is associated with reduced length of stay and no increased rate of refeeding syndrome. Hypophosphatemia during nutritional rehabilitation in anorexia nervosa: implications for refeeding and monitoring. Cardiac arrest and delirium: presentations of the refeeding syndrome in severely malnourished adolescents with anorexia nervosa. Use of total parenteral nutrition in the refeeding of selected patients with severe anorexia nervosa. Evaluation of a healthy-weight treatment program for bulimia nervosa: a preliminary randomized trial. Gastric emphysema, a critical condition accompanied by eating disorders: a case report. Eating disorders and the intestinal microbiota: mechanisms of energy homeostasis and behavioral influence. Food allergies are usually characterized as IgE-mediated ("immediate") or non-IgE-mediated ("delayed"); the latter are presumed to be cell-mediated. Other than peanut and tree nuts, most childhood food allergies are outgrown by the end of the first decade. Most of these reactions occur in adolescents and adults who have seasonal allergic rhinitis and are due to cross-reactivity between homologous proteins in pollens. A positive local reaction (Prausnitz-Küstner test) proved sensitivity could be transferred by a factor in serum (immunoglobulin [Ig]E antibodies) from an allergic to a non-allergic individual. Toxic reactions will occur in any exposed individual following ingestion of a sufficient dose. Non-toxic reactions depend on individual susceptibilities and may be immune mediated (food allergy or food hypersensitivity) or non-immune mediated (food intolerance). Food intolerances comprise most adverse food reactions and are categorized as enzymatic, pharmacologic, or idiopathic. Secondary lactase deficiency is an enzymatic intolerance adults (see Chapter 104), whereas most other enzyme deficiencies are rare inborn errors of metabolism and thus primarily affect infants and children. Pharmacologic food intolerances are present in individuals who are abnormally reactive to substances like vasoactive amines, which are normally present in some foods. These scattered immune cells make up the effector sites of the mucosal immune system and function to recognize and clear pathogenic challenges from the environment. Specialized epithelial cells (M cells) overlie Peyer patches and contribute to the selective uptake of particulate antigens into this site. Lack of reactivity to our commensal flora is in part achieved by a specialized regulatory environment that may also shape the immune response to antigens derived from the diet. Developmental immaturity of various components of the intestinal barrier and immune system reduces the efficiency of the infant mucosal barrier; the activity of various enzymes is suboptimal in the newborn period, and the secretory immunoglobulin A (sIgA) system is not fully mature until 4 years of age. Despite the evolution of this complex mucosal barrier, about 2% of ingested food antigens are absorbed and transported through the normal mature intestine and throughout the body in an immunologically intact form. As first described in 1911 by Osborne and Wells,22 antigens ingested via the oral route induce a systemic nonresponsiveness that has been termed oral tolerance. Antigens first ingested and then injected in an attempt to immunize an animal could not elicit an immune response. Similar findings have been demonstrated in humans following feeding and immunization with a neoantigen, keyhole limpet hemocyanin. An important source of the precursor for retinoic acid comes from the diet in the form of vitamin A. It has now been shown that there are approximately the same number of bacterial cells in the human body as there are human cells. Immunoreactivity to foods may occur through immunoglobulin (Ig)E-, non-IgE, and mixed mechanisms. Sensitization to food allergens in IgE-mediated disease occurs primarily through exposure through inflamed skin. Upon re-exposure to allergen an immediate, IgE-mediated reaction may ensue, resulting in anaphylaxis. The intestinal microbiota is relatively stable throughout life after reaching the adult pattern somewhere after the first year of life. Studies in sensitized rats have indicated that intestinal antigen transport proceeds in 2 phases. Loosening of the tight junctions occurs as a result of factors released by mast cells that are activated in the first phase. Whereas the first antigen-specific pathway involves antibody, the second nonspecific pathway most likely involves cytokines.

References

• Yew WW, Chan CK, Chau CH, et al. Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens. Chest 2000; 117: 744-751.
• Lee HK, Kwon HJ, Lee HB, Jin GY, Chung MJ, Lee YC. Radiofrequency thermal ablation of primary pleural synovial sarcoma. Respiration 2006;73(2):250-2.
• Cox KL, Frates RC J., Wong A, Gandhi G. Hereditary generalized juvenile polyposis associated with pulmonary arteriovenous malformation. Gastroenterology 1980;78:1566.
• Sommer T, Fehske W, Holzknecht N, et al. Aortic dissection: a comparative study of diagnosis with spiral CT, multiplanar transesophageal echocardiography, and MR imaging. Radiology 1996; 199:347-352.